Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.
|
|
Volume 6 (2010), Issue 11 (November)
- The discovery and development of analgesics: new mechanisms, new modalities.
J Clin Invest, 120(11): 3753-9. [Abstract] [Full-text]
- Biomarkers in Alzheimer's disease drug development.
Nat Med, 16(11): 1218-22. [Abstract] [Full-text]
- Overcoming obstacles to developing new analgesics.
Nat Med, 16(11): 1241-7. [Abstract] [Full-text]
- Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development.
Methods Mol Biol, 683: 553-72. [Abstract] [Full-text]
- Therapeutic applications of cell-penetrating peptides.
Methods Mol Biol, 683: 535-51. [Abstract] [Full-text]
- Interindividual variations in the efficacy and toxicity of vaccines.
Toxicology, 278(2): 204-10. [Abstract] [Full-text]
- Interindividual variations in the efficacy and toxicity of vaccines.
Toxicology, 278(2): 204-10. [Abstract] [Full-text]
- Interindividual variations in the efficacy and toxicity of vaccines.
Toxicology, 278(2): 204-10. [Abstract] [Full-text]
- Grand challenge commentary: Accessing new chemical space for 'undruggable' targets.
Nat Chem Biol, 6(12): 861-3. [Abstract] [Full-text]
- Grand challenge commentary: Accessing new chemical space for 'undruggable' targets.
Nat Chem Biol, 6(12): 861-3. [Abstract] [Full-text]
- Demonstrating utility of pharmacogenetics in pediatric populations: methodological considerations.
Clin Pharmacol Ther, 88(6): 757-9. [Abstract] [Full-text]
- Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
Clin Pharmacol Ther, 88(6): 749-51. [Abstract] [Full-text]
- Developing pharmacogenetic evidence throughout clinical development.
Clin Pharmacol Ther, 88(6): 867-70. [Abstract] [Full-text]
- Breaking barriers in the genomics and pharmacogenetics of drug addiction.
Clin Pharmacol Ther, 88(6): 779-91. [Abstract] [Full-text]
- Probabilistic risk analysis: improving early drug development decision making.
Clin Pharmacol Ther, 88(6): 871-5. [Abstract] [Full-text]
- Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
J Natl Cancer Inst, 102(22): 1698-705. [Abstract] [Full-text]
- Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.
Clin Pharmacol Ther, 88(6): 792-5. [Abstract] [Full-text]
- Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.
Arterioscler Thromb Vasc Biol, 30(12): 2372-84. [Abstract] [Full-text]
- Demonstrating utility of pharmacogenetics in pediatric populations: methodological considerations.
Clin Pharmacol Ther, 88(6): 757-9. [Abstract] [Full-text]
- Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
Clin Pharmacol Ther, 88(6): 749-51. [Abstract] [Full-text]
- Developing pharmacogenetic evidence throughout clinical development.
Clin Pharmacol Ther, 88(6): 867-70. [Abstract] [Full-text]
- Breaking barriers in the genomics and pharmacogenetics of drug addiction.
Clin Pharmacol Ther, 88(6): 779-91. [Abstract] [Full-text]
- Probabilistic risk analysis: improving early drug development decision making.
Clin Pharmacol Ther, 88(6): 871-5. [Abstract] [Full-text]
- Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
J Natl Cancer Inst, 102(22): 1698-705. [Abstract] [Full-text]
- Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.
Clin Pharmacol Ther, 88(6): 792-5. [Abstract] [Full-text]
- Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.
Arterioscler Thromb Vasc Biol, 30(12): 2372-84. [Abstract] [Full-text]
- Demonstrating utility of pharmacogenetics in pediatric populations: methodological considerations.
Clin Pharmacol Ther, 88(6): 757-9. [Abstract] [Full-text]
- Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
Clin Pharmacol Ther, 88(6): 749-51. [Abstract] [Full-text]
- Developing pharmacogenetic evidence throughout clinical development.
Clin Pharmacol Ther, 88(6): 867-70. [Abstract] [Full-text]
- Breaking barriers in the genomics and pharmacogenetics of drug addiction.
Clin Pharmacol Ther, 88(6): 779-91. [Abstract] [Full-text]
- Probabilistic risk analysis: improving early drug development decision making.
Clin Pharmacol Ther, 88(6): 871-5. [Abstract] [Full-text]
- Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.
Clin Pharmacol Ther, 88(6): 792-5. [Abstract] [Full-text]
- Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey.
J Am Acad Dermatol, 63(6): 1000-5. [Abstract] [Full-text]
- Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey.
J Am Acad Dermatol, 63(6): 1000-5. [Abstract] [Full-text]
- Björn Ekwall, an outstanding Swedish cell toxicologist.
Toxicol In Vitro, 24(8): 2060-2. [Abstract] [Full-text]
- Is pharmacogenetic CYP2D6 testing useful?
Tidsskr Nor Laegeforen, 130(22): 2224-8. [Abstract] [Full-text]
- Is pharmacogenetic CYP2D6 testing useful?
Tidsskr Nor Laegeforen, 130(22): 2224-8. [Abstract] [Full-text]
- Will the ubiquitin system furnish as many drug targets as protein kinases?
Cell, 143(5): 686-93. [Abstract] [Full-text]
- The chemical basis of pharmacology.
Biochemistry, 49(48): 10267-76. [Abstract] [Full-text]
- The chemical basis of pharmacology.
Biochemistry, 49(48): 10267-76. [Abstract] [Full-text]
© 2005-2013 Pharmacology Research Today. All Rights Reserved.
|
|